Role of Epstein‐Barr Virus and Human Papilloma Virus in the Development of Oropharyngeal Cancer: A Literature Review
Open Access
- 1 January 2022
- journal article
- review article
- Published by Wiley in International Journal of Dentistry
- Vol. 2022 (1) , 3191569
Abstract
The aim of this review was to describe the association and related mechanisms between HPV, EBV, and the development of oral and oropharyngeal cancer. A search for scientific evidence was carried out in electronic databases (MEDLINE/PubMed, SciELO). It was found that, among the carcinogenic mechanisms of HPV, E6 and E7 proteins are responsible for the malignization process, inhibiting tumor suppressors p53 and pRb. As to EBV, it was noted that its “hit and run” phenomenon manipulates the host epigenetic mechanism, triggering the tumor process without the virus being currently present; a “cellular reprogramming” is essentially generated, causing heritable changes in gene expression without DNA mutation. In conclusion, there is an association between oropharyngeal carcinogenesis and HPV and also between the former and EBV. Further studies are required to clarify the causal mechanisms and impact of both viruses on cancer development and to obtain biomarkers of greater specificity in the case of EBV.Keywords
This publication has 36 references indexed in Scilit:
- The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancerThe Laryngoscope, 2016
- Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, PeruSexually Transmitted Infections, 2015
- Epidemiology of Virus Infection and Human Cancer2013
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa RicaPLOS ONE, 2013
- Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin’s lymphoma in paraffin-embedded tissuesMolecular Medicine Reports, 2012
- HPV-associated head and neck cancer: a virus-related cancer epidemicThe Lancet Oncology, 2010
- Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancerOral Oncology, 2010
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive WomenJNCI: Journal of the National Cancer Institute, 2005
- Tongue and tonsil carcinomaCancer, 2005